Alcon Science | United States

This page is available in English. Select below for other countries.

Select other country

PHARMACEUTICAL

Dry Eye

    SYSTANE/OTC

    Preservative-Free Eye Drops

     

    SYSTANE® COMPLETE Preservative-Free Eye Drops

     

    SYSTANE® HYDRATION Preservative-Free Eye Drops

     

    SYSTANE® ULTRA Preservative-Free Eye Drops

     

    SYSTANE® Preservative-Free Eye Drops

     

    Lubricant Eye Drops

     

    SYSTANE® COMPLETE Lubricant Eye Drops

     

    SYSTANE® ULTRA Lubricant Eye Drops

     

    SYSTANE® BALANCE Lubricant Eye Drops

     

    SYSTANE® Lubricant Eye Drops

     

    Rewetting Eye Drops

     

    SYSTANE® CONTACTS Rewetting Eye Drops

     

    EYSUVIS®

     

    Recent Scientific Publications on Dry Eye

     

     

     

    WHITE PAPER

     

     

    Evolution of Systane® Artificial Tears

     

     

     

    WHITE PAPER

     

    Thermal Pulsation Systems and Topical Immunomodulators for Managing Meibomian Gland Dysfunction

     

     

    CLINICAL SCIENCE COMPENDIA

     

     

    Systane iLux Clinical Science Compendium

     

     

     

    PERSPECTIVES ON VISION

     

    Preoperative Dry Eye Management with Systane iLux2

     

     

     

     

    WHITE PAPER

     

    Scientific Overview of Ocular Lubricants in the United States

     

     

     

     

    WHITE PAPER

     

    SYSTANE® HYDRATION PF's Dual-Polymer Technology: Hydroxypropyl-Guar and Sodium Hyaluronate

     

     

       

      EYSUVIS® is the first and only FDA-approved corticosteroid for short-term dry eye treatment.

       

      IMPORTANT SAFETY INFORMATION

       

      EYSUVIS® should not be used if you have a viral infection in your eye. Talk to your doctor before using EYSUVIS® if you think you may have a viral, bacterial, or fungal eye infection.

       

      Your doctor should examine your eyes before prescribing EYSUVIS®, to check for increased eye pressure or damage to the surface of the eye.

       

      Consult your doctor if pain, redness, itching, or inflammation develops or gets worse. Wash your hands well before each use.

       

      Do not allow the dropper tip to touch any surface, as this may contaminate the suspension. Shake the bottle for two to three seconds before using. If a dose is missed, take the missed dose when remembered.

       

      Remove contact lenses before using EYSUVIS®; they may be reinserted 15 minutes later. The most common adverse drug reaction following the use of EYSUVIS® for two weeks was instillation site pain, which was reported in 5% of patients.

       

      View Full Prescribing Information Here